You are here

Article info

Article menu
Download PDFPDF
Uterine Cancer
Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer

Authors

  1. Address correspondence and reprint requests to Shari Damast, MD, Yale Therapeutic Radiology, Hunter Bldg, 15 York St, Ste HRT 136, New Haven, CT 06510. E-mail: shari.damast{at}yale.edu.

Citation

Lester-Coll NH, Young MR, Park HS, et al
Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer
International Journal of Gynecologic Cancer 2017;27:1904-1911.

Publication history

  • Received April 16, 2017
  • Accepted June 28, 2017
  • First published November 1, 2017.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.